Brief: AcelRx Pharmaceuticals Announces Publication Of Clinical Data On Use Of Sufentanil Sublingual Tablet During Awake Plastic Surgery Procedures
01/02/2022 13:34
Feb 1 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS ANNOUNCES PUBLICATION OF CLINICAL
DATA ON
THE USE OF SUFENTANIL SUBLINGUAL TABLET DURING AWAKE PLASTIC
SURGERY PROCEDURES
Source text for Eikon: ID:nPn15VC8Ra
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial